NextDocs announced that leading pharmaceutical and biologics companies implemented late last year the NextDocs clinical solution suite
NextDocs announced that leading pharmaceutical and biologics companies implemented late last year the NextDocs clinical solution suite across more than 200 clinical trials to manage regulated content and compliance, and bring together clinical trial constituencies onto a single management system.
The pharma sponsor initially deployed the NextDocs eTMF solution over two years ago to manage clinical trial documents. In 2013, the company expanded the deployment to include Clinical Research Organization (CRO) access. Subsequently, the company deployed the NextDocs Trial Exchange (TrX) investigator portal solution to provide external access to a user community of over 30,000 investigators across more than 10,000 trial sites.
Read the full release here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.